QUINJA (Novum Pharma, LLC)


Welcome to the PulseAid listing for the QUINJA drug offered from Novum Pharma, LLC. This pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
LABELER NAME / MANUFACTURER: Novum Pharma, LLC
NON-PROPRIETARY NAME: Iodoquinol and Aloe Polysaccharide
SUBSTANCE NAME: IODOQUINOL; ALOE VERA LEAF
TYPE: HUMAN PRESCRIPTION DRUG
PHARMA CLASS:
ROUTE: TOPICAL
DOSAGE FORM: GEL
MARKETING CATEGORY NAME: UNAPPROVED DRUG OTHER
START MARKETING DATE: 2017-07-20
END MARKETING DATE: 0000-00-00


QUINJA HUMAN PRESCRIPTION DRUG Details:

Item DescriptionQUINJA from Novum Pharma, LLC
LABELER NAME: Novum Pharma, LLC
DEA SCHEDULE:
ACTIVE STRENGTH: 12.5; 10(mg/g; mg/g)
START MARKETING DATE: 2017-07-20
END MARKETING DATE: 0000-00-00
PRODUCT ID: 69646-716_ce66d7ba-5689-4c1c-8961-7df8236ba46d
PRODUCT NDC: 69646-716
APPLICATION NUMBER:

Other IODOQUINOL; ALOE VERA LEAF Pharmaceutical Manufacturers / Labelers:

Manufacturer / LabelerProprietary Name
Novum Pharma, LLCAloquin